Molecular methods for antimicrobial resistance (AMR) diagnostics to enhance the Global Antimicrobial Resistance Surveillance System

Antimicrobial resistance (AMR) is a serious threat to global public health. In 2015, WHO launched the Global Antimicrobial Resistance Surveillance System (GLASS) in order to standardize the collection of data on AMR for planning, prevention and intervention programmes. Reports to GLASS currently rely on detection of phenotypic resistance, however in the future, GLASS may incorporate the results of molecular testing for AMR detection by appropriate methods. Molecular diagnostic methods can be used with phenotypic testing to yield additional information. This technical note provides information to those involved at various levels of AMR surveillance in choosing the most appropriate molecular AMR test for their setting, including clinical and reference laboratories. The document also provides a review of available methods and how they could be used in national surveillance.

Click Link for Report: Report

The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017

The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed, and temporal trends assessed. ‘Microbiological’ resistance was assessed using epidemiological cut-off (ECOFF) values; for some countries, qualitative data on human isolates were interpreted in a way which corresponds closely to the ECOFF-defined ‘microbiological’ resistance.

Click on link to download the Report Report PDF

New policy brief on tackling antibiotic resistance provides policy guidance using a cultural contexts approach

Understanding how cultural factors shape the use, transmission and regulation of antibiotics can help improve the fight against antibiotic resistance (ABR), argues a new WHO policy brief launched today. ABR is a critical contemporary global health challenge. By helping to recast ABR as a social and cultural as well as a biological issue, the policy brief broadens the basis for possible policy intervention and action to reduce ABR.

Click link for report: Report

UK 20-year vision for Antimicrobial Resistance

Click to Link: UK 20-year vision for antimicrobial resistance

The vision and plan were developed across the government, its agencies and administrations in Scotland, Wales and Northern Ireland, with support from a range of stakeholders.

It is supported by the UK 5-year action plan for antimicrobial resistance 2019 to 2024. Click to Link

Both documents build on the achievements of the UK 5-year AMR strategy 2013 to 2018.

UK One Health Report: antibiotic use and antibiotic resistance in animals and humans

Click on Link: One Health Report

The second UK One-Health Report is a cross-government initiative that brings together UK data (2013-2017), on antibiotic resistance in key bacteria that are common to animals and humans, and isolated in meat at retail.

The report also includes details on amount of antibiotics sold for use in animals and antibiotics prescribed to humans.

The report aims to:
•support joint working between the animal, human, environment and food sectors
•assess the occurrence of resistance along the food chain
•add context to the surveillance data by providing information on control measures in place to reduce the risk of bacterial transmission and on policy decisions taken to tackle antibiotic resistance
•identify the current antibiotic resistance levels in four key bacteria in animals, in humans and in retail meat
•present available data from humans, animals and retail meat side by side
•provide progress updates on the ten recommendations made in the previous One Health Report

One Health European Joint Programme 1st Annual Scientific Meeting, Dublin May 2019

1st ANNUAL SCIENTIFIC MEETING OF THE ONE HEALTH EUROPEAN JOINT PROGRAMME ON FOOD-BORNE ZOONOSES, ANTIMICROBIAL RESISTANCE AND EMERGING THREATS

This meeting takes place in Dublin on May 22nd-24th 2019

The conference organising team are delighted to invite you to attend the first Annual Scientific Meeting of the One Health European Joint Programme OHEJP on food-borne zoonoses, antimicrobial resistance and emerging threats. The first One Health EJP Annual Scientific Meeting, is being jointly hosted by Teagasc and NUI Galway and held at the Teagasc Conference Centre, Ashtown, Dublin.

The conference is organised by Dr Geraldine Duffy, Teagasc (Chair) and Dr Dearbháile Morris, National University of Ireland Galway (Co- chair) in collaboration with a local organising team at Teagasc, National University of Galway, Department of Agriculture, Food and the Marine, Food Safety Authority of Ireland, University College Dublin, Health Protection Surveillance Centre and the EJP project management team.

Click on Link: One Health EJP 1st ASM

UK Government promises more funding to fight superbugs

The UK government has agreed an extra £10 million to fight antimicrobial resistance (AMR) at home and abroad.

•£9 million to the Foundation for Innovative New Diagnostics (FIND)
•£1.5 million funding for a fellowship programme in developing countries to build capacity for calculating and mitigating the economic cost of AMR
•£1 million to an International Reference Centre providing practical support to developing countries to improve their ability to collect data on AMR to better tackle it across human health, animal health, agriculture and the environment

Click to Link: UK Government Funding